<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Evan Albright — Digest tagged &quot;tax-policy&quot;</title><description>Digest issues tagged #tax-policy.</description><link>https://www.evanalbright.com/</link><language>en-us</language><item><title>OpenAI&apos;s custom chip arrives as Anthropic accuses Alibaba of model extraction</title><link>https://www.evanalbright.com/digest/2026-06-25/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-06-25/</guid><description>Anthropic accused Alibaba of illicitly extracting Claude&apos;s model capabilities, drawing 829 Hacker News comments and raising fresh questions about AI IP enforcement. OpenAI unveiled Jalapeño, its first custom inference chip built with Broadcom, a move that reshapes its dependency on Nvidia. GLM-5.2 crossed a threshold Nathan Lambert called the step change for open agents. Google introduced computer use in Gemini 3.5 Flash, and U.S. health spending rose 7.3% in 2025, driven by GLP-1 drug adoption and higher care utilization. A bipartisan bill would expand methadone access by letting physicians prescribe it outside specialty clinics.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>ai</category><category>pharma</category><category>economy</category><category>software</category><category>healthtech</category><category>open-weights</category><category>chip</category><category>glp-1</category><category>agents</category><category>benchmarks</category><category>legal</category><category>china</category><category>post-quantum</category><category>clinical-trials</category><category>labor</category><category>stablecoins</category><category>ev</category><category>industrial-policy</category><category>business-formation</category><category>methadone</category><category>ebola</category><category>cardiac</category><category>drug-discovery</category><category>prompt-injection</category><category>computer-use</category><category>inference</category><category>hardware</category><category>developer-tools</category><category>sustainability</category><category>claude</category><category>ip</category><category>anthropic</category><category>openai</category><category>broadcom</category><category>glm</category><category>chinese-models</category><category>llm</category><category>gemini</category><category>google</category><category>multimodal</category><category>qualcomm</category><category>m&amp;a</category><category>edge-ai</category><category>evals</category><category>leaderboards</category><category>methodology</category><category>security</category><category>safety</category><category>hiring</category><category>code-generation</category><category>authenticity</category><category>databricks</category><category>enterprise</category><category>strategy</category><category>data-centers</category><category>cooling</category><category>nvidia</category><category>infrastructure</category><category>retrieval</category><category>embeddings</category><category>language</category><category>reasoning</category><category>policy</category><category>regulation</category><category>geopolitics</category><category>finance</category><category>business</category><category>fable</category><category>cost</category><category>optimization</category><category>frameworks</category><category>tools</category><category>knowledge</category><category>training</category><category>fine-tuning</category><category>open-source</category><category>fraud</category><category>cryptography</category><category>software-engineering</category><category>management</category><category>oauth</category><category>auth</category><category>cloudflare</category><category>rust</category><category>http</category><category>debugging</category><category>sqlite</category><category>mcp</category><category>data</category><category>health-spending</category><category>cms</category><category>economics</category><category>infectious-disease</category><category>who</category><category>gilead</category><category>opioids</category><category>addiction</category><category>legislation</category><category>biotech</category><category>biosecurity</category><category>vaccines</category><category>bio-conference</category><category>mrna</category><category>transgender</category><category>doj</category><category>healthcare</category><category>lgbtq</category><category>privacy</category><category>market</category><category>down-syndrome</category><category>ethics</category><category>disability</category><category>treatment</category><category>confidentiality</category><category>psychiatry</category><category>hair-loss</category><category>spending</category><category>clinical-trial</category><category>fda</category><category>cardiology</category><category>prediction</category><category>ecg</category><category>sudden-cardiac-death</category><category>nature</category><category>investors</category><category>eli-lilly</category><category>investment</category><category>screening</category><category>preventive-medicine</category><category>mri</category><category>evidence</category><category>cost-benefit</category><category>entrepreneurship</category><category>dynamism</category><category>startups</category><category>wages</category><category>inequality</category><category>macro</category><category>federal-reserve</category><category>clean-energy</category><category>obesity</category><category>marriage</category><category>behavioral</category><category>nih</category><category>health-policy</category><category>crypto</category><category>financial-stability</category><category>risk</category><category>history</category><category>london</category><category>philosophy</category><category>housing</category><category>affordability</category><category>research</category><category>science</category><category>links</category><category>tech</category><category>grants</category><category>fellowships</category><category>innovation</category><category>culture</category><category>uk</category><category>politics</category><category>substack</category><category>wellbeing</category><category>aging</category><category>macroeconomics</category><category>tax-policy</category><category>wealth</category><category>nordic-countries</category></item><item><title>AbbVie buys Apogee for $11B as pharma&apos;s $123B deal wave rolls on</title><link>https://www.evanalbright.com/digest/2026-06-22/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-06-22/</guid><description>AbbVie agreed to acquire Apogee Therapeutics for nearly $11 billion, the latest in a pharma M&amp;A wave that has totaled $123 billion in 2026 deals so far. Definium&apos;s LSD therapy met its primary endpoint in a Phase 3 trial for major depression, and the FDA reversed a four-month-old rejection of Regenxbio&apos;s gene therapy for Hunter syndrome. In AI, Samsung deployed ChatGPT Enterprise and Codex to employees worldwide in one of OpenAI&apos;s largest enterprise rollouts, while Nathan Lambert and Kevin Xu argued that banning open-source AI would damage US interests. Patrick Boyle examined how SpaceX humiliated Wall Street and Cuba announced its most sweeping economic reforms in decades, including private banking and the end of fuel subsidies.</description><pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate><category>ai</category><category>pharma</category><category>economy</category><category>software</category><category>healthtech</category><category>open-weights</category><category>m&amp;a</category><category>export-control</category><category>psychedelics</category><category>fda</category><category>spacex</category><category>llm</category><category>enterprise</category><category>biotech</category><category>cuba</category><category>codex</category><category>deployment</category><category>evals</category><category>cybersecurity</category><category>agents</category><category>benchmarks</category><category>open-source</category><category>policy</category><category>geopolitics</category><category>claude</category><category>safety</category><category>identity</category><category>anthropic</category><category>cost</category><category>models</category><category>cloudflare</category><category>infrastructure</category><category>software-engineering</category><category>glm</category><category>chinese-models</category><category>security</category><category>sqlite</category><category>tools</category><category>database</category><category>mcp</category><category>architecture</category><category>fable</category><category>research</category><category>language</category><category>strategy</category><category>xai</category><category>competition</category><category>datasette</category><category>governance</category><category>conferences</category><category>architectures</category><category>transformers</category><category>debugging</category><category>training</category><category>whisper</category><category>fine-tuning</category><category>lora</category><category>jepa</category><category>vision</category><category>events</category><category>community</category><category>attention</category><category>kernels</category><category>voice</category><category>optimization</category><category>deno</category><category>runtime</category><category>desktop</category><category>startups</category><category>labor</category><category>fraud</category><category>sovereign-ai</category><category>scaling</category><category>theory</category><category>web</category><category>seo</category><category>standards</category><category>rust</category><category>graphics</category><category>imaging</category><category>civil-society</category><category>inference</category><category>javascript</category><category>python</category><category>data</category><category>migrations</category><category>engineering</category><category>immunology</category><category>abbvie</category><category>dealmaking</category><category>financing</category><category>depression</category><category>clinical-trials</category><category>phase3</category><category>gene-therapy</category><category>rare-disease</category><category>pediatrics</category><category>nih</category><category>health-equity</category><category>funding</category><category>atopic-dermatitis</category><category>lsd</category><category>diversity</category><category>deals</category><category>mental-health</category><category>cmo</category><category>pipeline</category><category>letters</category><category>opinion</category><category>style</category><category>terminology</category><category>industry</category><category>personnel</category><category>disability</category><category>grants</category><category>emergency-medicine</category><category>addiction</category><category>healthcare</category><category>drug-discovery</category><category>r&amp;d</category><category>sanofi</category><category>ipo</category><category>business</category><category>markets</category><category>private-equity</category><category>valuation</category><category>china</category><category>reform</category><category>emerging-markets</category><category>fintech</category><category>payments</category><category>banking</category><category>tax-policy</category><category>economics</category><category>tcja</category><category>employment</category><category>california</category><category>regulation</category><category>demographics</category><category>europe</category><category>religion</category><category>books</category><category>recommendations</category><category>consumer-behavior</category><category>technology</category><category>unintended-consequences</category><category>capitalism</category><category>latin-america</category><category>music</category><category>globalization</category><category>aesthetics</category><category>philosophy</category><category>links</category><category>national-identity</category><category>japan</category><category>poetry</category><category>sweden</category><category>media</category><category>writing</category><category>influence</category><category>mexico</category><category>growth</category><category>trade</category><category>covid</category><category>bubbles</category><category>venture-capital</category></item></channel></rss>